ABUS

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Arbutus Biopharma (ABUS) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ABUS is expected to report earnings to fall 14.00% to -8 cents per share on February 27

Arbutus Biopharma ABUS Stock Earnings Reports

Q4'24

Est.

$-0.09

Q3'24

Missed

by $0.01

Q2'24

Missed

by $0.01

Q1'24

Est.

$-0.10

Q4'23

Est.

$-0.12

The last earnings report on November 06 showed earnings per share of -10 cents, missing the estimate of -9 cents. With 45.24K shares outstanding, the current market capitalization sits at 608.27M.

View a ticker or compare two or three

Compare

ABUS

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ABUS
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ABUS (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of drugs to improve the treatment of cancer

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

701 Veterans Circle

Phone

+1 267 469-0914

Employees

Web

http://www.arbutusbio.com